U.S. SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                                   FORM 12B-25
                           NOTIFICATION OF LATE FILING
                            SEC File Number 000-29461
                                   Form 10-QSB
                           For Period Ending: 03/31/07

                      ------------------------------------
                         PART I: REGISTRANT INFORMATION
                      ------------------------------------

Full Name of Registrant: Organetix, Inc. ("OGTX")

Address of Principal Executive Office: c/o Rubin, Bailin, Ortoli LLP, 405 Park
Avenue, 15th Floor, New York, New York 10022-4405

Phone - (440) 238-8316

                      ------------------------------------
                        PART II: RULES 12B-25(B) AND (C)
                      ------------------------------------

It is anticipated that the subject Quarterly Report on Form 10-QSB will be filed
within the next several days.

                      ------------------------------------
                               PART III: NARRATIVE
                      ------------------------------------

The Registrant has not completed its Quarterly Report on Form 10-QSB for the
period ended March 31, 2007, due to administrative delays.

                      ------------------------------------
                           PART IV: OTHER INFORMATION
                      ------------------------------------

(1) Name and telephone number of person(s) to contact in regard to this
notification

Dr. David F. Hostelley, Chief Executive Officer (440) 238-8316

(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).

|X| YES |_| NO

(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

|_| YES |X| NO



If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

Organetix, Inc. has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.

Dated: May 11, 2007
                                        ORGANETIX, INC.

                                        By: /s/ Dr. David F. Hostelley
                                            --------------------------
                                            Dr. David F. Hostelley
                                            President